Wilczyńska M, Cierniewski C S
Department of Biophysics, Institute of Physiology and Biochemistry, Medical School, Lódź, Poland.
Thromb Haemost. 1990 Apr 12;63(2):246-50.
A peptide fragment of tissue plasminogen activator (tPA) corresponding to amino acid residues 4-8 (tPA4-8) was synthesized, coupled to thyroglobulin and injected into rabbits. Antibodies specific to the peptide tPA4-8 were purified immunochemically on the pentapeptide coupled to CNBr-Sepha rose 4B. Anti-tPA4-8 antibodies, reacted with iodinated peptide tPA4-8, showing a relatively high binding affinity (KD = 2.3 x 10(-8) M). There was no interaction between anti-tPA4-8 antibodies and native one- or two-chain tPA. However, reduction of disulfide bonds unmasked the epitope on the heavy chain of tPA which became accessible to anti-tPA4-8 antibodies. Similarly, complexing of tPA with alpha 1-antitrypsin inhibitor resulted in unmasking of the epitope formed by amino acid residues in the positions 4-8. Presented data suggest that complexing of tPA with inhibitors results in conformational changes occurring in the "finger" domain of tPA molecule and such conformational transition can be detected by antipeptide antibodies. Therefore, anti-tPA4-8 antibodies may be employed as sequence-specific reporter molecules to monitor local conformational changes in tPA molecule.
合成了组织型纤溶酶原激活剂(tPA)对应于氨基酸残基4 - 8的肽片段(tPA4 - 8),将其与甲状腺球蛋白偶联后注射到兔子体内。针对肽tPA4 - 8的特异性抗体通过免疫化学方法在偶联于溴化氰活化的琼脂糖4B的五肽上进行纯化。抗tPA4 - 8抗体与碘化肽tPA4 - 8反应,显示出相对较高的结合亲和力(KD = 2.3×10⁻⁸ M)。抗tPA4 - 8抗体与天然的单链或双链tPA之间没有相互作用。然而,二硫键的还原暴露出tPA重链上的表位,使其能够与抗tPA4 - 8抗体结合。同样,tPA与α1 - 抗胰蛋白酶抑制剂的复合导致由4 - 8位氨基酸残基形成的表位暴露。所呈现的数据表明,tPA与抑制剂的复合导致tPA分子“指状”结构域发生构象变化,并且这种构象转变可以通过抗肽抗体检测到。因此,抗tPA4 - 8抗体可作为序列特异性报告分子来监测tPA分子中的局部构象变化。